What insurance policy changes affect CPT 33981?

There are 6 tracked policy changes affecting CPT 33981, including updates from Aetna, Independence Blue Cross, Humana. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 33981?

Payers that have issued tracked updates for CPT 33981 include: Aetna, Independence Blue Cross, Humana.

How do I get notified when CPT 33981 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 33981. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 33981?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

33981 — Surgically replacing a mechanical heart pump device that was implanted outside the body.: Insurance Policy Changes

33981 Insurance Policy Changes

CPT 33981, in plain terms, covers Surgically replacing a mechanical heart pump device that was implanted outside the body. CPT 33981 is referenced in 6 tracked payer policy changes from Aetna, Independence Blue Cross, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 33981 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

High impact

Ventricular Assist Devices (CPB 0654, reviewed 2026-09-10)

Aetna·Identified Oct 5, 2026

Aetna updated its Ventricular Assist Device (VAD) medical policy (CPB 0654) with clarified coverage criteria for FDA-approved devices across multiple indications including bridge to transplant, destination therapy, refractory electrical storm, percutaneous VADs, pediatric VADs, temporary circulatory support, and the Impella RP System. The policy explicitly identifies which procedures and devices are experimental/investigational (including aortic counter-pulsation systems and concomitant mitral valve surgery with LVAD). Billing teams must verify member eligibility against specific clinical criteria (NYHA Class IV, LVEF <25%, peak VO2 ≤14 mL/kg/min, etc.) before processing claims.

33981 Insurance Policy Changes

Ventricular Assist Devices (CPB 0654, reviewed 2026-09-10)

MA11.011i, Ventricular Assist Devices (VADs)

Ventricular Assist Device, Total Artificial Heart - Medicare Advantage (Revised)

11.02.16u, Ventricular Assist Devices (VADs)

Ventricular Assist Device, Total Artificial Heart - Medicare Advantage (Revised)

11.02.16u, Ventricular Assist Devices (VADs)